MARKET

PFE

PFE

Pfizer
NYSE
24.11
+0.39
+1.64%
Opening 13:14 07/07 EDT
OPEN
24.09
PREV CLOSE
23.72
HIGH
24.35
LOW
24.01
VOLUME
22.04M
TURNOVER
--
52 WEEK HIGH
28.28
52 WEEK LOW
21.97
MARKET CAP
137.41B
P/E (TTM)
18.42
1D
5D
1M
3M
1Y
5Y
1D
Moderately bullish activity in Pfizer with shares up 1.33%
TipRanks · 8h ago
Opinion: Pfizer's Dividend Is Riskier Than You Might Think
The Motley Fool · 9h ago
Pfizer (PFE) Stock Bounces Back After an Analyst Downgrade
TipRanks · 9h ago
Pfizer call volume above normal and directionally bullish
TipRanks · 9h ago
The Bull Case For Pfizer (PFE) Could Change Following First CDK4/6 Maintenance Approval In HER2-Positive Breast Cancer
Simply Wall St · 9h ago
Manhattan High-Rise at Risk of Collapse, Prompting Evacuations -- Update
The Wall Street Journal · 10h ago
VT, BLK, HON, PFE: Large Inflows Detected at ETF
NASDAQ · 10h ago
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?
NASDAQ · 12h ago
More
About PFE
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.

Webull offers Pfizer Inc stock information, including NYSE: PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.